# Kinnate Biopharma Inc.

Kinnate Biopharma Inc. is a company headquartered in San Diego, CA, United States.

## Company overview

- **Legal name:** Kinnate Biopharma Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** San Diego, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001797768

## About

Kinnate Biopharma Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001797768, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-03-28, it reported net income of USD -112,649,000; total assets of USD 173,605,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Net income:** -$112.6M (USD -112,649,000)
- **Total assets:** $173.6M (USD 173,605,000)
- **Cash and equivalents:** $57.0M (USD 56,998,000)
- **Operating cash flow:** -$100.0M (USD -100,043,000)

### FY2022 (period ended 2022-12-31)

- **Net income:** -$116.3M (USD -116,271,000)
- **Total assets:** $278.8M (USD 278,826,000)
- **Cash and equivalents:** $29.3M (USD 29,261,000)
- **Operating cash flow:** -$89.0M (USD -89,034,000)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$89.8M (USD -89,763,000)
- **Total assets:** $366.9M (USD 366,864,000)
- **Cash and equivalents:** $116.1M (USD 116,096,000)
- **Operating cash flow:** -$71.1M (USD -71,065,000)

## Recent SEC filings

- Form 8-K — filed 2024-04-03 — period 2024-04-03 — 8-K
- Form 10-K — filed 2024-03-28 — period 2023-12-31 — 10-K
- Form 8-K — filed 2024-03-01 — period 2024-02-27 — FORM 8-K
- Form 8-K — filed 2024-02-16 — period 2024-02-16 — FORM 8-K
- Form 8-K — filed 2024-01-16 — period 2024-01-09 — 8-K
- Form SC 13G — filed 2023-11-27
- Form 8-K — filed 2023-11-22 — period 2023-11-16 — 8-K
- Form 8-K — filed 2023-11-15 — period 2023-11-13 — 8-K
- Form 10-Q — filed 2023-11-09 — period 2023-09-30 — 10-Q
- Form 8-K — filed 2023-11-09 — period 2023-11-09 — 8-K
- Form 8-K — filed 2023-09-18 — period 2023-09-15 — 8-K
- Form 10-Q — filed 2023-08-08 — period 2023-06-30 — 10-Q

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/kinnate-biopharma-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology